Shahbazi Hamed bought NAGE

June 24, 2025 · Form 4 insider transaction

Shahbazi Hamed bought 20,000 shares of Niagen Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 9 days after the transaction.

Direction

Acquired (buy-side)

20,000

Price

$0.00

Total value

N/A

InsiderShahbazi Hamed

Role—

CompanyNiagen Bioscience, Inc. (NAGE)

SecurityStock Option (right to buy)

Transaction codeA — Grant or award

Transaction dateJune 24, 2025

Filing dateJuly 3, 2025

Shares owned after20,000

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Option vests 100% on June 24, 2026.

View the original Form 4 on SEC EDGAR